TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Workday Lead
Play
INVESTING

10 Best Stocks in the Nasdaq on Tuesday: Workday Climbs

  • By Fatma Khaled
  • Dec 22, 2020 6:58 PM EST
Workday Lead
INVESTING

10 Best Stocks in the Nasdaq on Tuesday: Workday Climbs

  • By Fatma Khaled
  • Dec 22, 2020 6:58 PM EST
Tesla Rises
INVESTING

12 Best Stocks in the Nasdaq This Past Week: Tesla Drives High

  • By Fatma Khaled
  • Dec 19, 2020 10:30 AM EST
PRESS RELEASES

DEADLINE TODAY: The Schall Law Firm Announces It Is Investigating Claims Against BioMarin Pharmaceutical Inc. And Encourages Investors With Losses Of $100,000 To Contact The Firm

  • By Business Wire
  • Nov 24, 2020 9:13 AM EST
PRESS RELEASES

BIOMARIN 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General And Kahn Swick & Foti, LLC Remind Investors With Losses In Excess Of $100,000 Of Deadline In Class Action Lawsuit Against BioMarin Pharmaceutical Inc. - BMRN

  • By PR Newswire
  • Nov 23, 2020 10:50 PM EST
PRESS RELEASES

BIOMARIN 48 HOUR DEADLINE ALERT: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Deadline In Class Action Lawsuit Against BioMarin Pharmaceutical Inc. - BMRN

  • By Business Wire
  • Nov 22, 2020 10:50 PM EST
PRESS RELEASES

BIOMARIN 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General And Kahn Swick & Foti, LLC Remind Investors With Losses In Excess Of $100,000 Of Deadline In Class Action Lawsuit Against BioMarin Pharmaceutical Inc. - BMRN

  • By Business Wire
  • Nov 20, 2020 10:50 PM EST
PRESS RELEASES

BMRN Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds BioMarin Pharmaceutical Inc. Shareholders Of Class Action And Lead Plaintiff Deadline: November 24, 2020

  • By Business Wire
  • Nov 19, 2020 11:00 AM EST
PRESS RELEASES

ROSEN, GLOBAL INVESTOR COUNSEL, Reminds BioMarin Pharmaceutical Inc. Investors Of Important November 24 Deadline In Securities Class Action; Encourages Investors With Losses In Excess Of $100K To Contact The Firm - BMRN

  • By PR Newswire
  • Nov 18, 2020 11:18 PM EST
PRESS RELEASES

ROSEN, A LEADING LAW FIRM, Reminds BioMarin Pharmaceutical Inc. Investors Of Important November 24 Deadline In Securities Class Action - BMRN

  • By Business Wire
  • Nov 11, 2020 5:30 PM EST
PRESS RELEASES

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In BioMarin Pharmaceuticals, Inc. Of Class Action Lawsuit And Upcoming Deadline - BMRN

  • By PR Newswire
  • Oct 31, 2020 11:22 PM EDT
PRESS RELEASES

ROSEN, TRUSTED INVESTOR COUNSEL, Reminds BioMarin Pharmaceutical Inc. Investors Of Important November 24 Deadline In Securities Class Action; Encourages Investors With Losses In Excess Of $100K To Contact Firm - BMRN

  • By PR Newswire
  • Oct 30, 2020 7:44 PM EDT
PRESS RELEASES

Glancy Prongay & Murray LLP Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against BioMarin Pharmaceuticals, Inc. (BMRN)

  • By PR Newswire
  • Oct 23, 2020 12:00 PM EDT
PRESS RELEASES

ROSEN, A TOP RANKED LAW FIRM, Reminds BioMarin Pharmaceutical Inc. Investors Of Important Deadline In Securities Class Action - BMRN

  • By Business Wire
  • Oct 22, 2020 4:24 PM EDT
PRESS RELEASES

DEADLINE REMINDER: Law Offices Of Howard G. Smith Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against BioMarin Pharmaceuticals Inc. (BMRN)

  • By PR Newswire
  • Oct 21, 2020 12:00 PM EDT
PRESS RELEASES

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In BioMarin Pharmaceuticals, Inc. Of Class Action Lawsuit And Upcoming Deadline - BMRN

  • By PR Newswire
  • Oct 17, 2020 6:22 PM EDT
PRESS RELEASES

ROSEN, A TOP RANKED LAW FIRM, Reminds BioMarin Pharmaceutical Inc. Investors Of Important Deadline In Securities Class Action; Encourages Investors With Losses In Excess Of $100K To Contact The Firm - BMRN

  • By PR Newswire
  • Oct 15, 2020 4:45 PM EDT
PRESS RELEASES

BMRN Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies BioMarin Pharmaceutical Inc. Shareholders Of Class Action And Lead Plaintiff Deadline: November 24, 2020

  • By Business Wire
  • Oct 8, 2020 11:00 AM EDT
PRESS RELEASES

ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Reminds BioMarin Pharmaceutical Inc. Investors Of Important Deadline In Securities Class Action - BMRN

  • By Business Wire
  • Oct 6, 2020 3:49 PM EDT
PRESS RELEASES

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Announces Filing Of Securities Class Action Lawsuit Against BioMarin Pharmaceutical Inc.; Encourages Investors With Losses In Excess Of $100K To Contact Firm - BMRN

  • By PR Newswire
  • Oct 2, 2020 7:50 PM EDT
PRESS RELEASES

The Law Offices Of Frank R. Cruz Announces The Filing Of A Securities Class Action On Behalf Of BioMarin Pharmaceuticals Inc. (BMRN) Investors

  • By Business Wire
  • Oct 2, 2020 11:30 AM EDT
PRESS RELEASES

Glancy Prongay & Murray LLP Announces The Filing Of A Securities Class Action On Behalf Of BioMarin Pharmaceuticals Inc. (BMRN) Investors

  • By Business Wire
  • Oct 1, 2020 4:00 PM EDT
PRESS RELEASES

INVESTOR ALERT: Law Offices Of Howard G. Smith Announces Investigation Of BioMarin Pharmaceuticals Inc. (BMRN) On Behalf Of Investors

  • By Business Wire
  • Oct 1, 2020 2:00 PM EDT
PRESS RELEASES

Glancy Prongay & Murray LLP, A Leading Securities Fraud Law Firm, Announces Investigation Of BioMarin Pharmaceuticals Inc. (BMRN) On Behalf Of Investors

  • By Business Wire
  • Sep 30, 2020 8:07 PM EDT
PRESS RELEASES

BIOMARIN SHAREHOLDER ALERT By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against BioMarin Pharmaceutical Inc. - BMRN

  • By Business Wire
  • Sep 30, 2020 4:57 PM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.